Genome-Wide Identification of lncRNA and mRNA for Diagnosing Type 2 Diabetes in Saudi Arabia

References

• Al Saeed MS, Awad NS, El-Tarras AE. Prevalence of some genetic polymorphisms among cardiovascular patients residing at high altitude and sea level. Int J Curr Microbiol App Sci. 2015;4(11):443–449.
   Google Scholar
• Fadl MA, Al-Yasi HM, Alsherif EA. Impact of elevation and slope aspect on floristic composition in wadi Elkor, Sarawat Mountain. Saudi J Biol Sci. 2021;11(1):1–10.
   Google Scholar
• Ulloa NA, Cook J. Altitude Induced Pulmonary Hypertension. StatPearls; 2020.
   Google Scholar
• Ely BR, Lovering AT, Horowitz M, et al. Heat acclimation and cross tolerance to hypoxia: bridging the gap between cellular and systemic responses. Temperature. 2014;1(2):107–114. doi:10.4161/temp.29800
   PubMedGoogle Scholar
• Tso E. High-altitude illness. Emerg Med Clin North Am. 1992;10(2):231–247. doi:10.1016/S0733-8627(20)30711-2
   PubMedGoogle Scholar
• Mairbäurl H. Red blood cells in sports: effects of exercise and training on oxygen supply by red blood cells. Front Physiol. 2013;4:332. doi:10.3389/fphys.2013.00332
   PubMed Web of Science ®Google Scholar
• Clerici C, Planès C. Gene regulation in the adaptive process to hypoxia in lung epithelial cells. Am J Physiol Cell Physiol. 2009;296(3):L267–L274. doi:10.1152/ajplung.90528.2008
   Web of Science ®Google Scholar
• Hackett PH, Roach RC. High-Altitude Illness. N Engl J Med. 2001;345(2):107–114. doi:10.1056/NEJM200107123450206
   PubMed Web of Science ®Google Scholar
• McGrath C. Highlight: The Epigenetics of Life at 12,000 Ft. Oxford University Press; 2021.
   Google Scholar
• Singh D, Bhattarai M. High prevalence of diabetes and impaired fasting glycaemia in urban Nepal. Diab Med. 2003;20(2):170–171. doi:10.1046/j.1464-5491.2003.00829_4.x
   PubMed Web of Science ®Google Scholar
• Sasaki H, Kawasaki T, Ogaki T, et al. The prevalence of diabetes mellitus and impaired fasting glucose/glycaemia (IFG) in suburban and rural Nepal—the communities-based cross-sectional study during the democratic movements in 1990. Diabetes Res Clin Pract. 2005;67(2):167–174. doi:10.1016/j.diabres.2004.06.012
   PubMed Web of Science ®Google Scholar
• Carrasco Piña E, Pérez Bravo F, Ángel Badillo B, et al. Prevalence of Type 2 Diabetes and Obesity in Two Chilean Aboriginal Populations Living in Urban Zones. Soc Medica Santiago; 2004.
   Google Scholar
• Okumiya K, Sakamoto R, Kimura Y, et al. Diabetes mellitus and hypertension in elderly highlanders in Asia. J Am Geriatr Soc. 2010;58(6):1193–1195. doi:10.1111/j.1532-5415.2010.02862.x
   PubMed Web of Science ®Google Scholar
• Wagner K-H, Schwingshackl L, Draxler A, et al. Impact of dietary and lifestyle interventions in elderly or people diagnosed with diabetes, metabolic disorders, cardiovascular disease, cancer and micronutrient deficiency on micronuclei frequency–a systematic review and meta-analysis. Mutat Res Rev Mutat Res. 2021;787:108367. doi:10.1016/j.mrrev.2021.108367
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Robert AA, Abdulaziz Al Dawish M, Braham R, et al. Type 2 diabetes mellitus in Saudi Arabia: major challenges and possible solutions. Curr Diabetes Rev. 2017;13(1):59–64.
   PubMedGoogle Scholar
• Gómez-Peralta F, Abreu C, Cos X, et al. When does diabetes start? Early detection and intervention in type 2 diabetes mellitus. Rev Clin Esp. 2020;220(5):305–314. doi:10.1016/j.rce.2019.12.003
   PubMed Web of Science ®Google Scholar
• Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–149.
   PubMed Web of Science ®Google Scholar
• Kadamkode V, Banerjee G. Micro RNA: an epigenetic regulator of type 2 diabetes. Microrna. 2014;3(2):86–97.
   PubMedGoogle Scholar
• Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol (Lausanne). 2013;4:37. doi:10.3389/fendo.2013.00037
   PubMedGoogle Scholar
• Florez JC, Hirschhorn J, Altshuler D. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet. 2003;4(1):257–291.
   PubMedGoogle Scholar
• Kwak SH, Park KS. Recent progress in genetic and epigenetic research on type 2 diabetes. Exp Mol Med. 2016;48(3):e220–e220.
   PubMed Web of Science ®Google Scholar
• Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet. 2012;13(10):679–692.
   PubMed Web of Science ®Google Scholar
• Geach T. Blood-based markers for T2DM. Nat Rev Endocrinol. 2016;12(6):311. doi:10.1038/nrendo.2016.63
   PubMedGoogle Scholar
• Bloss CS, Jeste DV, Schork NJ. Genomics for disease treatment and prevention. Psychiatr Clin. 2011;34(1):147–166.
   Google Scholar
• Burton H, Jackson C, Abubakar I. The impact of genomics on public health practice. Br Med Bull. 2014;112(1):37.
   PubMed Web of Science ®Google Scholar
• Salzman J, Chen RE, Olsen MN, et al. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9(9):e1003777. doi:10.1371/journal.pgen.1003777
   PubMed Web of Science ®Google Scholar
• Gloss BS, Dinger ME. Realizing the significance of noncoding functionality in clinical genomics. Exp Mol Med. 2018;50(8):1–8. doi:10.1038/s12276-018-0087-0
   PubMedGoogle Scholar
• Cebola I, Pasquali L. Non-coding genome functions in diabetes 1 2; 2015.
   Google Scholar
• Zhang P, Wu W, Chen Q, et al. Non-Coding RNAs and their Integrated Networks. J Integr Bioinform. 2019;16(3):20190027. doi:10.1515/jib-2019-0027
   PubMed Web of Science ®Google Scholar
• López-Jiménez E, Andrés-León E. The Implications of ncRNAs in the development of human diseases. Non-Coding RNA. 2021;7(1):17. doi:10.3390/ncrna7010017
   PubMed Web of Science ®Google Scholar
• May JM, Bylicky M, Chopra S, et al. Long and short non-coding RNA and radiation response: a review. Transl Res. 2021;233:162–179. doi:10.1016/j.trsl.2021.02.005
   PubMed Web of Science ®Google Scholar
• He X, Ou C, Xiao Y, et al. LncRNAs: key players and novel insights into diabetes mellitus. Oncotarget. 2017;8(41):71325. doi:10.18632/oncotarget.19921
   PubMedGoogle Scholar
• Vance KW, Ponting CP. Transcriptional regulatory functions of nuclear long noncoding RNAs. Trends Genet. 2014;30(8):348–355. doi:10.1016/j.tig.2014.06.001
   PubMed Web of Science ®Google Scholar
• Knauss JL, Sun T. Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function. Neuroscience. 2013;235:200–214. doi:10.1016/j.neuroscience.2013.01.022
   PubMed Web of Science ®Google Scholar
• Kazemzadeh M, Safaralizadeh R, Orang AV. LncRNAs: emerging players in gene regulation and disease pathogenesis. J Genet. 2015;94(4):771–784. doi:10.1007/s12041-015-0561-6
   PubMed Web of Science ®Google Scholar
• Pastori C, Wahlestedt C. Involvement of long noncoding RNAs in diseases affecting the central nervous system. RNA Biol. 2012;9(6):860–870. doi:10.4161/rna.20482
   PubMed Web of Science ®Google Scholar
• Chen D, Sun Q, Cheng X, et al. Genome-wide analysis of long noncoding RNA (lnc RNA) expression in colorectal cancer tissues from patients with liver metastasis. Cancer Med. 2016;5(7):1629–1639. doi:10.1002/cam4.738
   PubMed Web of Science ®Google Scholar
• Sauvageau M, Goff LA, Lodato S, et al. Multiple knockout mouse models reveal lincRNAs are required for life and brain development. elife. 2013;2:e01749. doi:10.7554/eLife.01749
   PubMed Web of Science ®Google Scholar
• Sallam T, Sandhu J, Tontonoz P. Long noncoding RNA discovery in cardiovascular disease: decoding form to function. Circ Res. 2018;122(1):155–166. doi:10.1161/CIRCRESAHA.117.311802
   PubMed Web of Science ®Google Scholar
• Simion V, Haemmig S, Feinberg MW. LncRNAs in vascular biology and disease. Vascul Pharmacol. 2019;114:145–156. doi:10.1016/j.vph.2018.01.003
   PubMed Web of Science ®Google Scholar
• Guo F-X, Wu Q, Li P, et al. The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling. Cell Death Differ. 2019;26(9):1670–1687. doi:10.1038/s41418-018-0235-z
   PubMed Web of Science ®Google Scholar
• Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 2003;52(3):812–817. doi:10.2337/diabetes.52.3.812
   PubMed Web of Science ®Google Scholar
• Herder C, Brunner EJ, Rathmann W, et al. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care. 2009;32(3):421–423. doi:10.2337/dc08-1161
   PubMed Web of Science ®Google Scholar
• Koçak MZ, Aktaş G, Erkuş E, et al. Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. Swiss Med Wkly. 2019;2019:1.
   Google Scholar
• Aktas G, Yilmaz S, Kantarci DB, et al. Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med. 2023;135(5):519–523. doi:10.1080/00325481.2023.2214058
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras. 2019;65:9–15. doi:10.1590/1806-9282.65.1.9
   PubMed Web of Science ®Google Scholar
• Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134(3):297–302. doi:10.1080/00325481.2022.2039007
   PubMed Web of Science ®Google Scholar
• Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras. 2021;67:549–554. doi:10.1590/1806-9282.20201005
   PubMed Web of Science ®Google Scholar
• Aktaş G, Kocak MZ, Duman TT, et al. Mean Platelet Volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity. Bali Med J. 2018;2018:1.
   Google Scholar
• Group, IDFGD. Global guideline for type 2 diabetes. Diabetes Res Clin Pract. 2014;104(1):1–52. doi:10.1016/j.diabres.2012.10.001
   PubMed Web of Science ®Google Scholar
• Kim D, Langmead B, Salzberg SL. HISAT: hierarchical indexing for spliced alignment of transcripts. BioRxiv. 2014;2014:012591.
   Google Scholar
• Pertea M, Pertea GM, Antonescu CM, et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33(3):290–295. doi:10.1038/nbt.3122
   PubMed Web of Science ®Google Scholar
• Sun L, Luo H, Bu D, et al. Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Res. 2013;41(17):e166–e166. doi:10.1093/nar/gkt646
   PubMed Web of Science ®Google Scholar
• Punta M, Coggill PC, Eberhardt RY, et al. The Pfam protein families database. Nucleic Acids Res. 2012;40(D1):D290–D301. doi:10.1093/nar/gkr1065
   PubMed Web of Science ®Google Scholar
• Frazee AC, Pertea G, Jaffe AE, et al. Ballgown bridges the gap between transcriptome assembly and expression analysis. Nat Biotechnol. 2015;33(3):243–246. doi:10.1038/nbt.3172
   PubMed Web of Science ®Google Scholar
• Young MD, Wakefield MJ, Smyth GK, et al. Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol. 2010;11(2):1–12. doi:10.1186/gb-2010-11-2-r14
   Web of Science ®Google Scholar
• Kanehisa M, Araki M, Goto S, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2007;36(suppl_1):D480–D484. doi:10.1093/nar/gkm882
   PubMedGoogle Scholar
• Mao X, Cai T, Olyarchuk JG, et al. Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics. 2005;21(19):3787–3793. doi:10.1093/bioinformatics/bti430
   PubMed Web of Science ®Google Scholar
• Gollapalli M, Alansari A, Alkhorasani H, et al. A novel stacking ensemble for detecting three types of diabetes mellitus using a Saudi Arabian dataset: pre-diabetes, T1DM, and T2DM. Comput Biol Med. 2022;147:105757. doi:10.1016/j.compbiomed.2022.105757
   PubMed Web of Science ®Google Scholar
• Al Dawish MA, Robert AA. Diabetes Mellitus in Saudi Arabia: challenges and possible solutions. In: Handbook of Healthcare in the Arab World. Springer; 2021:1083–1100.
   Google Scholar
• Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res. 2005;36(3):197–209. doi:10.1016/j.arcmed.2005.01.003
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Mohammad G. Epigenetic modifications in diabetes. Metabolism. 2022;126:154920. doi:10.1016/j.metabol.2021.154920
   PubMed Web of Science ®Google Scholar
• Arden K. FOXO animal models reveal a variety of diverse roles for FOXO transcription factors. Oncogene. 2008;27(16):2345–2350. doi:10.1038/onc.2008.27
   PubMed Web of Science ®Google Scholar
• Dansen TB, Burgering BM. Unravelling the tumor-suppressive functions of FOXO proteins. Trends Cell Biol. 2008;18(9):421–429. doi:10.1016/j.tcb.2008.07.004
   PubMed Web of Science ®Google Scholar
• Bakker WJ, Harris IS, Mak TW. FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2. Mol Cell. 2007;28(6):941–953. doi:10.1016/j.molcel.2007.10.035
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou Y, Graves DT. FOXO transcription factors: their clinical significance and regulation. Biomed Res Int. 2014;2014:1.
   Web of Science ®Google Scholar
• Behl Y, Krothapalli P, Desta T, et al. FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats. Diabetes. 2009;58(4):917–925. doi:10.2337/db08-0537
   PubMed Web of Science ®Google Scholar
• Sangwung P, Zhou G, Nayak L, et al. KLF2 and KLF4 control endothelial identity and vascular integrity. JCI Insight. 2017;2(4). doi:10.1172/jci.insight.91700
   PubMed Web of Science ®Google Scholar
• Dekker RJ, Van Soest S, Fontijn RD, et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood J Am Soc Hematol. 2002;100(5):1689–1698.
   Google Scholar
• Lin Z, Kumar A, SenBanerjee S, et al. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res. 2005;96(5):e48–e57. doi:10.1161/01.RES.0000159707.05637.a1
   PubMed Web of Science ®Google Scholar
• Atkins GB, Jain MK. Role of Kruppel-like transcription factors in endothelial biology. Circ Res. 2007;100(12):1686–1695. doi:10.1161/01.RES.0000267856.00713.0a
   PubMed Web of Science ®Google Scholar
• Lee H-Y, Youn S-W, Cho H-J, et al. FOXO1 impairs whereas statin protects endothelial function in diabetes through reciprocal regulation of Krüppel-like factor 2. Cardiovasc Res. 2013;97(1):143–152. doi:10.1093/cvr/cvs283
   PubMed Web of Science ®Google Scholar
• Lee H-Y, Youn SW, Oh BH, et al. Krüppel-like factor 2 suppression by high glucose as a possible mechanism of diabetic vasculopathy. Korean Circ J. 2012;42(4):239–245. doi:10.4070/kcj.2012.42.4.239
   PubMed Web of Science ®Google Scholar
• Bhattacharya R, SenBanerjee S, Lin Z, et al. Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J Biol Chem. 2005;280(32):28848–28851. doi:10.1074/jbc.C500200200
   PubMed Web of Science ®Google Scholar
• Wang H-G, Cao B, Zhang L-X, et al. KLF2 inhibits cell growth via regulating HIF-1α/Notch-1 signal pathway in human colorectal cancer HCT116 cells. Oncol Rep. 2017;38(1):584–590. doi:10.3892/or.2017.5708
   PubMed Web of Science ®Google Scholar
• Ziello JE, Jovin IS, Huang Y. Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med. 2007;80(2):51.
   PubMedGoogle Scholar
• Jensen KS, Binderup T, Jensen KT, et al. FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function. EMBO J. 2011;30(22):4554–4570. doi:10.1038/emboj.2011.323
   PubMed Web of Science ®Google Scholar
• Toffoli S, Roegiers A, Feron O, et al. Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1. Angiogenesis. 2009;12(1):47–67. doi:10.1007/s10456-009-9131-y
   PubMed Web of Science ®Google Scholar
• Kawanami D, Mahabeleshwar GH, Lin Z, et al. Kruppel-like factor 2 inhibits hypoxia-inducible factor 1α expression and function in the endothelium. J Biol Chem. 2009;284(31):20522–20530. doi:10.1074/jbc.M109.025346
   PubMed Web of Science ®Google Scholar
• Dutto I, Scalera C, Prosperi E. CREBBP and p300 lysine acetyl transferases in the DNA damage response. Cell Mol Life Sci. 2018;75(8):1325–1338. doi:10.1007/s00018-017-2717-4
   PubMed Web of Science ®Google Scholar
• Wensveen TT, Gašparini D, Rahelić D, et al. Type 2 diabetes and viral infection; cause and effect of disease. Diabetes Res Clin Pract. 2021;172:108637. doi:10.1016/j.diabres.2020.108637
   PubMed Web of Science ®Google Scholar
• Vojtek AB, Der CJ. Increasing complexity of the Ras signaling pathway. J Biol Chem. 1998;273(32):19925–19928. doi:10.1074/jbc.273.32.19925
   PubMed Web of Science ®Google Scholar
• El-Nasr NMA, Saleh DO, Mahmoud SS, et al. Olmesartan attenuates type 2 diabetes-associated liver injury: cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways. Eur J Pharmacol. 2020;874:173010. doi:10.1016/j.ejphar.2020.173010
   PubMed Web of Science ®Google Scholar
• Pereira LX, Alves da Silva LC, de Oliveira Feitosa A, et al. Correlation between renin-angiotensin system (RAS) related genes, type 2 diabetes, and cancer: insights from metanalysis of transcriptomics data. Mol Cell Endocrinol. 2019;493:110455. doi:10.1016/j.mce.2019.110455
   PubMed Web of Science ®Google Scholar
• Du X, Li X, Chen L, et al. Hepatic miR‐125b inhibits insulin signaling pathway by targeting PIK3CD. J Cell Physiol. 2018;233(8):6052–6066. doi:10.1002/jcp.26442
   PubMed Web of Science ®Google Scholar
• Liu H-M, Huang Y, Li L, et al. MicroRNA-mRNA expression profiles and functional network of submandibular gland in type 2 diabetic db/db mice. Arch Oral Biol. 2020;120:104947. doi:10.1016/j.archoralbio.2020.104947
   PubMed Web of Science ®Google Scholar
• Du Z, Uversky VN. A comprehensive survey of the roles of highly disordered proteins in type 2 diabetes. Int J Mol Sci. 2017;18(10):2010. doi:10.3390/ijms18102010
   PubMed Web of Science ®Google Scholar
• Yang F, Chen Y, Xue Z, et al. High-throughput sequencing and exploration of the lncRNA-circRNA-miRNA-mRNA network in type 2 diabetes mellitus. Biomed Res Int. 2020;2020:1.
   Web of Science ®Google Scholar
• Eldakhakhny BM, Al Sadoun H, Choudhry H, et al. In-Silico study of immune system associated genes in case of type-2 diabetes with insulin action and resistance, and/or obesity. Front Endocrinol (Lausanne). 2021;12:641888. doi:10.3389/fendo.2021.641888
   PubMed Web of Science ®Google Scholar
• Kado S, Nagase T, Nagata N. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetol. 1999;36:67–72. doi:10.1007/s005920050147
   PubMed Web of Science ®Google Scholar
• Wu X, Yu T, Ji N, et al. IL6R inhibits viability and apoptosis of pancreatic beta-cells in type 2 diabetes mellitus via regulation by miR-22 of the JAK/STAT signaling pathway. Diabetes Metab Syndr Obes. 2019;Volume 12:1645–1657. doi:10.2147/DMSO.S211700
   Web of Science ®Google Scholar
• Horsten U, Schmitz-Van de Leur H, Müllberg J, et al. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL‐6 and the IL‐6 receptor. FEBS Lett. 1995;360(1):43–46. doi:10.1016/0014-5793(95)00053-C
   PubMed Web of Science ®Google Scholar
• Moshapa FT, Riches-Suman K, Palmer TM. Therapeutic targeting of the proinflammatory IL-6-JAK/STAT signalling pathways responsible for vascular restenosis in type 2 diabetes mellitus. Cardiol Res Pract. 2019;2019:1–15. doi:10.1155/2019/9846312
   Web of Science ®Google Scholar
• Ghoreschi K, Laurence A, O’Shea JJ. Janus kinases in immune cell signaling. Immunol Rev. 2009;228(1):273–287. doi:10.1111/j.1600-065X.2008.00754.x
   PubMed Web of Science ®Google Scholar
• Gornicka AO, Millward C, Croniger C, Larner A. Deficiency of Tyk2 Kinase in Mice Leads to Obesity and Insulin Resistance. Wiley Online Library; 2008.
   Google Scholar
• Nagafuchi S, Kamada-Hibio Y, Hirakawa K, et al. TYK2 promoter variant and diabetes mellitus in the Japanese. E Bio Med. 2015;2(7):744–749.
   Google Scholar
• Amin S, Parker A, Mann J. ZAP70 in chronic lymphocytic leukaemia. Int J Biochem Cell Biol. 2008;40(9):1654–1658. doi:10.1016/j.biocel.2007.05.016
   PubMed Web of Science ®Google Scholar
• Huang Q, Deng G, Wei R, et al. Comprehensive identification of key genes involved in development of diabetes mellitus-related atherogenesis using weighted gene correlation network analysis. Front Cardiovasc Med. 2020;7:580573. doi:10.3389/fcvm.2020.580573
   PubMed Web of Science ®Google Scholar
• Efeyan A, Zoncu R, Sabatini DM. Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med. 2012;18(9):524–533. doi:10.1016/j.molmed.2012.05.007
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. cell. 2012;149(2):274–293. doi:10.1016/j.cell.2012.03.017
   PubMed Web of Science ®Google Scholar
• Rasheed N, Lima TB, Mercaldi GF, et al. C7orf59/LAMTOR4 phosphorylation and structural flexibility modulate Ragulator assembly. FEBS Open Bio. 2019;9(9):1589–1602. doi:10.1002/2211-5463.12700
   PubMed Web of Science ®Google Scholar
• Russell SA, Bashaw GJ. Axon guidance pathways and the control of gene expression. Dev Dyn. 2018;247(4):571–580. doi:10.1002/dvdy.24609
   PubMed Web of Science ®Google Scholar
• Das UN, Rao AA. Gene expression profile in obesity and type 2 diabetes mellitus. Lipids Health Dis. 2007;6:1–19. doi:10.1186/1476-511X-6-35
   PubMed Web of Science ®Google Scholar
• Guo K, Elzinga S, Eid S, et al. Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus. Epigenetics. 2019;14(8):766–779. doi:10.1080/15592294.2019.1615352
   PubMed Web of Science ®Google Scholar
• Sherif M. Understanding the Genetic Basis of Diabetes Mellitus and Sensorineural Deafness. UCL (University College London); 2015.
   Google Scholar
• Kleinstein SE, McCorrison J, Ahmed A, et al. Transcriptomics of type 2 diabetic and healthy human neutrophils. BMC Immunol. 2021;22(1):1–16. doi:10.1186/s12865-021-00428-6
   PubMed Web of Science ®Google Scholar